Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana

Keyphrases

• Adverse Events 100%
• Healthcare Workers 100%
• Accra-Ghana 100%
• HIV Pre-exposure Prophylaxis 100%
• Korle-Bu Teaching Hospital 100%
• Healthcare Students 94%
• Pre-exposure Prophylaxis (PrEP) 26%
• Lamivudine 15%
• Zidovudine 15%
• Antiviral Drugs 10%
• Cohort Event Monitoring 10%
• Treatment Adherence 5%
• Occupationally Exposed 5%
• Occupational Exposure 5%
• Regression Analysis 5%
• AIDS/HIV 5%
• Active Follow-up 5%
• Pharmacovigilance 5%
• HIV Infection 5%
• HIV Patients 5%
• Multivariate Analysis 5%
• Treatment Efficacy 5%
• Intolerance 5%
• Cox Regression 5%
• Nausea 5%
• Mobile Phone 5%
• Counseling Education 5%
• Chi-square Test 5%
• Preferred Terms 5%
• Medical Dictionary for Regulatory Activities (MedDRA) 5%
• People Living with HIV (PLHIV) 5%
• Non-adherence 5%
• Highly Active Antiretroviral Therapy (HAART) 5%
• Lopinavir 5%
• Cox Proportional Regression 5%
• HIV Seroconversion 5%
• Adverse Event Management 5%
• Monitoring Adverse Events 5%
• Phone Contacts 5%
• Organ Classification 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Cohort Study 100%
• HIV 100%
• Lamivudine 100%
• Zidovudine 100%
• Adverse Event 100%
• Lamivudine Plus Zidovudine 23%
• Pharmacovigilance 7%
• Lopinavir Plus Ritonavir 7%
• Occupational Exposure 7%
• Nausea 7%
• Human Immunodeficiency Virus Infection 7%
• MedDRA 7%